Mumbai-based MOC Cancer Care & Research introduces CAR-T Cell Therapy

The therapy has hekped to treat blood cancers, such as Leukemias, Myeloma and Lymphomas

MOC Cancer Care & Research Centre has introduced CAR-T Cell Therapy for patients in India to have access to this cutting-edge treatment option, which has already demonstrated remarkable success in treating certain blood cancers, such as Leukemias, Myeloma and Lymphomas, in countries where it is currently available.

Dr Suraj Chiraniya, a leading Hemato-Oncologist & BMT specialist at MOC Cancer Care, passionately underscored the critical role of early detection in the fight against blood cancer, stating, "We are thrilled to announce the imminent introduction of CAR-T cell therapy at MOC, a revolutionary advancement that harnesses the power of the patient's immune system to combat cancer more effectively than ever before."

Dr Ashray Kole, a leading Oncologist at MOC Cancer Care, emphasised the transformative potential of this revolutionary approach, stating, "CAR-T Cell Therapy represents a paradigm shift in the way we treat cancer. By making these advanced therapies more accessible and affordable, we aim to ensure that a greater number of patients can benefit from these life-saving treatments and have a fighting chance against even the most aggressive forms of cancer."